Home › Funds › Ikarian Capital, LLC › CNTB

Ikarian Capital, LLC position in CNTB

CONNECT BIOPHARMA HLDGS LTD · Health Care

Ikarian Capital, LLC reported holding 4,538,534 shares of CNTB (CONNECT BIOPHARMA HLDGS LTD) in its Q2 2026 13F filing — a position valued at US$10.8M, representing 1.73% of its reported portfolio and ranking #15 among its reported holdings. Ikarian Capital, LLC has disclosed CNTB holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)4.54M sh
Reported value held$10.80M
Portfolio Weight1.73%
First reportedQ4 2025
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Ikarian Capital, LLC's CNTB position evolved

Ikarian Capital, LLC first disclosed a stake in CNTB in Q4 2025 at 144,600 shares (US$408K). The position peaked in Q2 2026 at 4,538,534 shares, worth US$10.8M. Across 3 filings, Ikarian Capital, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 4,538,534 shares valued at US$10.8M — an increase of 4,393,934 shares quarter over quarter.. Notable position changes include a 3039% increase in Q2 2026 (shares fell 54% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 144.60K $407.77K New
Q1 2026 144.60K $378.85K Hold
Q2 2026 4.54M $10.80M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CNTB and 13F data

CNTB (CONNECT BIOPHARMA HLDGS LTD) is a Health Care company. 62 other funds we track also report a position in CNTB — the largest reported positions include BML Capital Management, LLC (US$1.4M), Richmond Brothers, Inc. (US$1.3M), Knott David M Jr (US$1.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CNTB

All CNTB fund holders →

FAQ

How long has Ikarian Capital, LLC held CNTB?

Ikarian Capital, LLC has disclosed CNTB holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Ikarian Capital, LLC's current position in CNTB?

As of Q2 2026, Ikarian Capital, LLC holds 4.54M shares of CNTB (CONNECT BIOPHARMA HLDGS LTD), valued at $10.80M, representing 1.73% of its reported portfolio and ranking #15.

Has Ikarian Capital, LLC been buying or selling CNTB?

In the latest 13F filing (Q2 2026), Ikarian Capital, LLC increased its position in CNTB. The position peaked in Q2 2026 at 4.54M shares.

Which other funds hold CNTB?

Other major institutional holders of CNTB include BML Capital Management, LLC, Richmond Brothers, Inc., Knott David M Jr, among 62 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.